Skip to main content
OpenTrials

Clinical trial condition

Skin Diseases, Vesiculobullous

Explore clinical trials studying Skin Diseases, Vesiculobullous. Study availability and eligibility vary by location and protocol.

240 public trials 35 recruiting studies
Refine in advanced search Browse all conditions

Skin Diseases, Vesiculobullous trial results

Recruiting

Efficacy and Safety Study to Evaluate SD-101 in Epidermolysis Bullosa

NCT07482787

Conditions
Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Epidermolysis Bullosa, +11 more
Locations
  • Mission Dermatology Rancho Santa Margarita, California, United States
  • Stanford University School of Medicine Dermatology Department Redwood City, California, United States
  • Medical University of South Carolina Department of Dermatology and Dermatologic Surgery Charleston, South Carolina, United States
View Trial Details
Recruiting

A Phase 2 Study of TCP-25 Gel in Patients With Epidermolysis Bullosa, STEP-study

NCT06594393

Conditions
Collagen Diseases, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +13 more
Locations
  • Hopital St Louis Paris, France
  • Andreas Syngros Hospital of Veneral & Dermatological Diseases Athens, Greece
  • Hospital Of Skin And Venereal Diseases of Thessaloniki Thessaloniki, Greece
  • IDI Istituto Dermopatico dell'Immacolata IRCCS Rome, Italy
View Trial Details
Recruiting

Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)

NCT06371417

Conditions
Antiphospholipid Syndrome, Antiphospholipid Syndrome (APS), Autoimmune Diseases, +50 more
Locations
  • University of California-Irvine Orange, California, United States
  • Johns Hopkins University Baltimore, Maryland, United States
  • Northwell Health, LLC PRIME Lake Success, New York, United States
  • Hospital for Special Surgery New York, United States
View all 77 locations
View Trial Details
Recruiting

A Long-Term Safety Follow-up Registry for Patients Who Received Treatment With Prademagene Zamikeracel for Recessive Dystrophic Epidermolysis Bullosa (RDEB) in the Post-Marketing Setting

NCT07700966

Conditions
Collagen Diseases, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +10 more
Locations
  • Lucile Packard Children's Hospital Palo Alto, California, United States
  • Children's Hospital Colorado Aurora, Colorado, United States
  • Ann & Robert H. Lurie Children's Hospital of Chicago - Department of Dermatology Chicago, Illinois, United States
  • University of Texas Medical Branch Galveston, Texas, United States
View Trial Details

Related conditions